Skip to main content
. 2012 Jun 19;6(1):19–26.

Fig 1.

Fig 1

A.The histo-pathological examination of the ovarian tissue of intact control group (Grade 0). B. The histo-pathological examination of the ovarian tissue of Moclobemide 10 mg/kg group (Grade 2). C. The histo-pathological examination of the ovarian tissue of Moclobemide 20 mg/kg group (Grade 1). D . The histo-pathological examination of the ovarian tissue of I/R control group. (Grade 3). E . The histo-pathological examination of the ovarian tissue of I/R control group. (Grade 4). F. The histo-pathological examination of the contralateral ovarian tissue of I/R group (Grade 1). G. The histo-pathological examination of the contralateral ovarian tissue of Moclobemide 10 mg/kg group (Grade 0). H. The histo-pathological examination of the contralateral ovarian tissue of Moclobemide 20 mg/kg group (Grade 0)